Current Report · Items 2.02, 9.01 · 8-K
Integrated BioPharma, Inc.
INBPOTCEQUITYCurrent
Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On September 25, 2026, Integrated Biopharma, Inc. (the “Company”) issued a press release announcing its financial results for the fiscal ended June 30, 2026. A copy of the press release is furnished as Exhibit 99.1 hereto and is hereby incorporated by reference into this Item 2.02.…
Press release in this filing
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2026 →Disclosure sections
Item 2.02Item 2.02 - Results of Operations
Item 2.02. Results of Operations and Financial Condition.
On September 25, 2026, Integrated Biopharma, Inc. (the “Company”) issued a press release announcing its financial results for the fiscal ended June 30, 2026. A copy of the press release is furnished as Exhibit 99.1 hereto and is hereby incorporated by reference into this Item 2.02.
The information in this Item 2.02 (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.